Forte Biosciences (FBRX) Misses Q3 EPS by 2c

Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• RH shares jump after second quarter beat
• RH (RH) Tops Q2 EPS by $2.31